'We've lost too many people': Alberta CF patients urge province to approve coverage for miracle drug
Cystic fibrosis patients in Alberta are urging the government to approve coverage for the drug Trikafta, now that Health Canada has approved the life-changing treatment for people with CF.
Cystic Fibrosis Canada estimates the transformational drug can treat up to 90 per cent of Canadians with cystic fibrosis. But until it’s funded by provincial drug plans, the treatment will remain inaccessible to those who need it.
“It is life-saving, life-changing, a miracle, all of those words,” said Amanda Bartels, a CF patient from Chestermere who became sick enough in 2020 to receive a compassionate supply of Trikafta.
“It started working within hours,” said Bartels.
“Over the next two weeks I was able to stop using my oxygen all the time, and going up a flight of stairs was no big deal.”
Last fall Bartels biked the Banff Legacy Trail from Banff to Canmore and back. It was an accomplishment she had never dreamed of two years ago, when she found something as easy as changing the bed sheets was a monumental task.
“You don’t realize how sick you are until you get that ability back,” said Bartels, who was approved to access Trikafta through a special Health Canada program that is only available to patients who are extremely ill.
Bartels had been undergoing assessment for a lung transplant and had been hospitalized for about six months in 2019 with a partially collapsed lung that wasn’t healing. She was constantly on oxygen, and even walking across the front yard was exhausting.
Drug treatment for cystic fibrosis
Amanda’s recovery and approval of Trikafta by Health Canada has inspired other CF patients, including Marten Devlieger, who moved from Taber to the Crowsnest Pass to take advantage of the mountain air.
“The hope it gives me, that I can hopefully live a normal long life and see my kids grow up, is absolutely amazing,” said Devlieger.
Devlieger was diagnosed with cystic fibrosis when he was two years old, and has been an advocate for better access to breakthrough treatments.
Devlieger’s sister Karen also had CF. She died in 2018 at the age of 33.
According to Marten, he has always lived for the day, and still does, but a drug like Trikafta offers hope for the future.
“I have two children. I used to never think of the future. I never thought of them getting married, I never thought of you know, retirement with my wife,” added Devlieger.
Cystic fibrosis is the most common fatal genetic disease in children and young adults in Canada.
Bartels said she was “super-excited” when Health Canada approved Trikafta last Friday, but her champagne is still on ice, “because we need the provinces to follow through and finish their part of the process quickly before it can get into patients hands.”
APPROVED IN 35 COUNTRIES
To date Trikafta has received regulatory approval in 35 countries and is publicly covered in nine countries so far.
According to CF Canada Trikafta costs roughly $300,000 US a year.
However patients point out it would save governments the cost of providing other medications and the expense of lengthy hospitalizations.
Devlieger, who is almost 40 years old and starting to experience complications such as liver disease and diabetes, realizes that time is not on his side.
“Every day more damage happens to me is closer to the end of life.”
Devlieger is urging the Alberta government to act quickly, and provide access to the drug as early as this summer.
“Let’s hope the right thing happens here and we can get it in our hands soon, and save lives.”
CTVNews.ca Top Stories
Montreal man on the hook for thousands of dollars after a feature on his Tesla caused an accident
A Montreal man is warning Tesla drivers about using the Smart Summon feature after his vehicle hit another in a parking lot.
B.C. man wants homes for thousands of books he soon won't be able to read
In the 10 years since John William started to lose his vision, he's been finding new ways to enjoy his vast personal library.
Israel closes Gaza crossing after Hamas attack and vows military operation 'in the very near future'
Israel closed its main crossing point for delivering badly needed humanitarian aid for Gaza on Sunday after Hamas militants attacked it, reportedly wounding several Israelis, while the defense minister warned of "a powerful operation in the very near future in Rafah and other places across all of Gaza."
No proof man lied to brother about number of kittens born in litter, B.C. tribunal rules
A man was denied a $5,000 payout from his brother after a B.C. tribunal dismissed his claim disputing how many kittens were born in a litter.
Chemical spill could be cause of stinky water in Puslinch, Ont., new report says
People living in Puslinch, Ont. may have the answer to why their water smelled so bad last year.
Mystik Dan wins the 150th Kentucky Derby at Churchill Downs in a three-horse photo finish
Mystik Dan won the 150th Kentucky Derby in a photo finish, edging out Forever Young and Sierra Leone for the upset victory.
opinion You don't need to be an influencer to earn income from social media
How legitimate are claims by some content creators that the average person can earn passive income from social media platforms like TikTok and Instagram? Personal finance columnist Christopher Liew says it's quite possible, if you're willing to put in the initial time and effort.
Denial and uncertainty are looming over a Biden-Trump rematch 6 months out from U.S. Election Day
Exactly six months before Election Day, Biden and Trump are locked in the first contest in 112 years with a current and former president competing for the White House. It's a race that is at once deeply entrenched and highly in flux as many voters are only just beginning to embrace the reality of the 2024 campaign.
Bombarded with spam texts? Stats show the problem is getting worse in Canada
In particular, messages that involve phishing — an attack where a scammer tries to trick the recipient into clicking a malicious link, downloading malware or sharing sensitive information — are on the rise.